Seongnam, South Korea

Mi Ra Seong

This inventor holds 1 USPTO granted patent. Top assignee: Hanmi Pharm. Co., Ltd.. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mi Ra Seong. Retrieved from https://idiyas.com/inventor/mi-ra-seong-dd0yd4b5

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mi Ra Seong: Innovator in Pharmaceutical Chemistry

Introduction

Mi Ra Seong is a notable inventor based in Seongnam-si, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the preparation of azithromycin. His innovative approach has led to advancements in the efficiency of drug production.

Latest Patents

Mi Ra Seong holds a patent for the "Process of preparing azithromycin and crystalline 9-deoxo-9a-aza-9a-homoerythromycin A hydrate used therein." This process allows for the preparation of azithromycin in a high yield through a simple method utilizing a crystalline 9-deoxo-9a-aza-9a-homoerythromycin A hydrate. This innovation is crucial for enhancing the production of this important antibiotic.

Career Highlights

Mi Ra Seong is currently employed at Hanmi Pharmaceutical Co., Ltd., where he continues to develop and refine pharmaceutical processes. His work has not only contributed to the company's success but has also had a positive impact on the healthcare industry.

Collaborations

Some of his notable coworkers include Gi Jeong Kim and Sang Min Yun. Their collaborative efforts have further advanced the research and development initiatives at Hanmi Pharmaceutical Co., Ltd.

Conclusion

Mi Ra Seong's contributions to pharmaceutical chemistry, particularly through his patent on azithromycin preparation, highlight his role as an innovator in the field. His work continues to influence the production of essential medications, showcasing the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…